$EXEL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EXELIXIS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in EXELIXIS, INC.. Get notifications about new insider transactions in EXELIXIS, INC. for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 35 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 5.04 | 75,000 | 378,000 | 0 | |
| Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 4.42 | 33,333 | 147,332 | 1,586,981 | 1.6 M to 1.6 M (+2.15 %) |
| Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 5.04 | 75,000 | 378,000 | 1,553,648 | 1.5 M to 1.6 M (+5.07 %) |
| Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 4.42 | 33,333 | 147,332 | 0 | |
| Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 5.04 | 75,000 | 378,000 | 0 | |
| Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 4.42 | 33,333 | 147,332 | 1,586,981 | 1.6 M to 1.6 M (+2.15 %) |
| Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 5.04 | 75,000 | 378,000 | 1,553,648 | 1.5 M to 1.6 M (+5.07 %) |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 1.70 | 34,267 | 58,254 | 570,284 | |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 1.70 | 100,000 | 170,000 | 604,551 | |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 1.70 | 100,000 | 170,000 | 704,551 | |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Sell | S | 20.91 | 34,267 | 716,523 | 125,000 | 159.3 K to 125 K (-21.52 %) |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 1.70 | 34,267 | 58,254 | 159,267 | 125 K to 159.3 K (+27.41 %) |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Sell | S | 21.02 | 100,000 | 2,102,000 | 125,000 | 225 K to 125 K (-44.44 %) |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 1.70 | 100,000 | 170,000 | 225,000 | 125 K to 225 K (+80.00 %) |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Sell | S | 21.10 | 100,000 | 2,110,000 | 125,000 | 225 K to 125 K (-44.44 %) |
| Aug 09 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 1.70 | 100,000 | 170,000 | 225,000 | 125 K to 225 K (+80.00 %) |
| Aug 08 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Sell | S | 20.92 | 2,361 | 49,392 | 124,917 | 127.3 K to 124.9 K (-1.85 %) |
| Aug 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 5.50 | 22,500 | 123,750 | 22,500 | |
| Aug 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Sell | S | 20.56 | 22,500 | 462,600 | 278,288 | 300.8 K to 278.3 K (-7.48 %) |
| Aug 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 5.50 | 22,500 | 123,750 | 300,788 | 278.3 K to 300.8 K (+8.09 %) |
| Jul 17 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 5.50 | 90,000 | 495,000 | 90,000 | |
| Jul 17 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Sell | S | 21.13 | 90,000 | 1,901,700 | 125,000 | 215 K to 125 K (-41.86 %) |
| Jul 17 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 5.50 | 90,000 | 495,000 | 215,000 | 125 K to 215 K (+72.00 %) |
| Jul 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 5.50 | 22,500 | 123,750 | 45,000 | |
| Jul 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Sell | S | 21.20 | 22,500 | 477,000 | 278,288 | 300.8 K to 278.3 K (-7.48 %) |
| Jul 03 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 5.50 | 22,500 | 123,750 | 300,788 | 278.3 K to 300.8 K (+8.09 %) |
| Jun 27 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 5.50 | 90,000 | 495,000 | 180,000 | |
| Jun 27 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Sell | S | 19.62 | 90,000 | 1,765,800 | 125,000 | 215 K to 125 K (-41.86 %) |
| Jun 27 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 5.50 | 90,000 | 495,000 | 215,000 | 125 K to 215 K (+72.00 %) |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Sell | S | 20.71 | 65,000 | 1,346,150 | 254,450 | 319.5 K to 254.5 K (-20.35 %) |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Option Exercise | M | 4.57 | 3,500 | 15,995 | 11,500 | |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Option Exercise | M | 4.16 | 11,250 | 46,800 | 0 | |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Sell | S | 20.60 | 34,262 | 705,797 | 15,221 | 49.5 K to 15.2 K (-69.24 %) |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Buy | M | 4.57 | 3,500 | 15,995 | 49,483 | 46 K to 49.5 K (+7.61 %) |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Buy | M | 4.16 | 11,250 | 46,800 | 45,983 | 34.7 K to 46 K (+32.39 %) |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 5.50 | 22,500 | 123,750 | 67,500 | |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Sell | S | 20.80 | 22,500 | 468,000 | 278,288 | 300.8 K to 278.3 K (-7.48 %) |
| Jun 01 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 5.50 | 22,500 | 123,750 | 300,788 | 278.3 K to 300.8 K (+8.09 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | Freire Maria C | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | Freire Maria C | Director | Grant | A | 0.00 | 7,937 | 0 | 22,057 | 14.1 K to 22.1 K (+56.21 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 5.50 | 90,000 | 495,000 | 270,000 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Sell | S | 20.55 | 90,000 | 1,849,500 | 125,000 | 215 K to 125 K (-41.86 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 5.50 | 90,000 | 495,000 | 215,000 | 125 K to 215 K (+72.00 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Grant | A | 0.00 | 7,937 | 0 | 101,781 | 93.8 K to 101.8 K (+8.46 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Grant | A | 0.00 | 7,937 | 0 | 91,335 | 83.4 K to 91.3 K (+9.52 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 7,937 | 0 | 1,042,251 | 1 M to 1 M (+0.77 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Grant | A | 0.00 | 7,937 | 0 | 133,850 | 125.9 K to 133.9 K (+6.30 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Sell | S | 21.40 | 50,000 | 1,070,000 | 418,273 | 468.3 K to 418.3 K (-10.68 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Grant | A | 0.00 | 7,937 | 0 | 101,781 | 93.8 K to 101.8 K (+8.46 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Grant | A | 0.00 | 7,937 | 0 | 91,335 | 83.4 K to 91.3 K (+9.52 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 7,937 | 0 | 1,042,251 | 1 M to 1 M (+0.77 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Grant | A | 0.00 | 7,937 | 0 | 133,850 | 125.9 K to 133.9 K (+6.30 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Sell | S | 21.40 | 50,000 | 1,070,000 | 418,273 | 468.3 K to 418.3 K (-10.68 %) |
| May 18 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Sell | S | 21.61 | 3,663 | 79,157 | 127,278 | 130.9 K to 127.3 K (-2.80 %) |
| May 16 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| May 16 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 11.66 | 15,000 | 174,900 | 1,478,648 | 1.5 M to 1.5 M (+1.02 %) |
| May 11 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| May 11 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Sell | S | 19.03 | 15,000 | 285,450 | 125,913 | 140.9 K to 125.9 K (-10.64 %) |
| May 11 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Buy | M | 11.66 | 15,000 | 174,900 | 140,913 | 125.9 K to 140.9 K (+11.91 %) |
| May 10 2018 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| May 10 2018 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Sell | S | 21.42 | 15,000 | 321,300 | 248,180 | 263.2 K to 248.2 K (-5.70 %) |
| May 10 2018 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Buy | M | 11.66 | 15,000 | 174,900 | 263,180 | 248.2 K to 263.2 K (+6.04 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 22.15 | 15,000 | 332,250 | 1,034,314 | 1 M to 1 M (-1.43 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 11.66 | 15,000 | 174,900 | 1,049,314 | 1 M to 1 M (+1.45 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Sell | S | 22.36 | 20,000 | 447,200 | 319,450 | 339.5 K to 319.5 K (-5.89 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Option Exercise | M | 1.90 | 15,000 | 28,500 | 60,000 | |
| May 07 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Option Exercise | M | 1.90 | 10,000 | 19,000 | 75,000 | |
| May 07 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Sell | S | 22.00 | 15,000 | 330,000 | 130,941 | 145.9 K to 130.9 K (-10.28 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Buy | M | 1.90 | 15,000 | 28,500 | 145,941 | 130.9 K to 145.9 K (+11.46 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Sell | S | 22.38 | 12,549 | 280,847 | 130,941 | 143.5 K to 130.9 K (-8.75 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Buy | M | 1.90 | 10,000 | 19,000 | 143,490 | 133.5 K to 143.5 K (+7.49 %) |
| May 04 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 5.50 | 22,500 | 123,750 | 90,000 | |
| May 04 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Sell | S | 23.47 | 14,700 | 345,009 | 278,288 | 293 K to 278.3 K (-5.02 %) |
| May 04 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Sell | S | 22.36 | 7,800 | 174,408 | 292,988 | 300.8 K to 293 K (-2.59 %) |
| May 04 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 5.50 | 22,500 | 123,750 | 300,788 | 278.3 K to 300.8 K (+8.09 %) |
| Apr 30 2018 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Option Exercise | M | 1.70 | 25,000 | 42,500 | 120,000 | |
| Apr 30 2018 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Buy | M | 1.70 | 25,000 | 42,500 | 339,450 | 314.5 K to 339.5 K (+7.95 %) |
| Apr 26 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Option Exercise | M | 1.70 | 20,000 | 34,000 | 65,000 | |
| Apr 26 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Buy | M | 1.70 | 20,000 | 34,000 | 133,490 | 113.5 K to 133.5 K (+17.62 %) |
| Apr 18 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| Apr 18 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Option Exercise | M | 7.97 | 15,000 | 119,550 | 0 | |
| Apr 18 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Sell | S | 20.25 | 14,959 | 302,920 | 93,844 | 108.8 K to 93.8 K (-13.75 %) |
| Apr 18 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Buy | M | 11.66 | 15,000 | 174,900 | 108,803 | 93.8 K to 108.8 K (+15.99 %) |
| Apr 18 2018 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Buy | M | 7.97 | 15,000 | 119,550 | 93,803 | 78.8 K to 93.8 K (+19.03 %) |
| Apr 18 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| Apr 18 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 20.25 | 15,000 | 303,750 | 61,329 | 76.3 K to 61.3 K (-19.65 %) |
| Apr 18 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 11.66 | 15,000 | 174,900 | 76,329 | 61.3 K to 76.3 K (+24.46 %) |
| Apr 13 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 5.50 | 90,000 | 495,000 | 360,000 | |
| Apr 13 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Sell | S | 20.78 | 90,000 | 1,870,200 | 131,653 | 221.7 K to 131.7 K (-40.60 %) |
| Apr 13 2018 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 5.50 | 90,000 | 495,000 | 221,653 | 131.7 K to 221.7 K (+68.36 %) |
| Apr 09 2018 | EXEL | EXELIXIS, INC. | Freire Maria C | Director | Option Exercise | A | 22.10 | 28,240 | 624,104 | 28,240 | |
| Apr 09 2018 | EXEL | EXELIXIS, INC. | Freire Maria C | Director | Grant | A | 0.00 | 14,120 | 0 | 14,120 | 0 to 14.1 K |
| Apr 06 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 7.18 | 14,591 | 104,763 | 163,109 | |
| Apr 06 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 7.18 | 14,591 | 104,763 | 277,280 | 262.7 K to 277.3 K (+5.55 %) |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Option Exercise | M | 11.66 | 11,000 | 128,260 | 0 | |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Sell | S | 23.88 | 11,000 | 262,680 | 34,733 | 45.7 K to 34.7 K (-24.05 %) |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Buy | M | 11.66 | 11,000 | 128,260 | 45,733 | 34.7 K to 45.7 K (+31.67 %) |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Option Exercise | M | 7.97 | 15,000 | 119,550 | 0 | |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Sell | S | 24.23 | 15,000 | 363,450 | 248,180 | 263.2 K to 248.2 K (-5.70 %) |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Buy | M | 7.97 | 15,000 | 119,550 | 263,180 | 248.2 K to 263.2 K (+6.04 %) |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Option Exercise | M | 7.97 | 15,000 | 119,550 | 0 | |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Sell | S | 24.73 | 15,000 | 370,950 | 125,913 | 140.9 K to 125.9 K (-10.64 %) |
| Mar 07 2018 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Buy | M | 7.97 | 15,000 | 119,550 | 140,913 | 125.9 K to 140.9 K (+11.91 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 4.42 | 7,293 | 32,235 | 0 | |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 4.42 | 7,293 | 32,235 | 262,689 | 255.4 K to 262.7 K (+2.86 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 7.97 | 15,000 | 119,550 | 0 | |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 24.05 | 15,000 | 360,750 | 1,034,314 | 1 M to 1 M (-1.43 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 7.97 | 15,000 | 119,550 | 1,049,314 | 1 M to 1 M (+1.45 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Option Exercise | M | 7.97 | 15,000 | 119,550 | 0 | |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Sell | S | 23.91 | 30,000 | 717,300 | 468,273 | 498.3 K to 468.3 K (-6.02 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Buy | M | 11.66 | 15,000 | 174,900 | 498,273 | 483.3 K to 498.3 K (+3.10 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Buy | M | 7.97 | 15,000 | 119,550 | 483,273 | 468.3 K to 483.3 K (+3.20 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Option Exercise | M | 5.50 | 3,000 | 16,500 | 0 | |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Option Exercise | M | 1.76 | 10,625 | 18,700 | 39,375 | |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Sell | S | 27.13 | 45,029 | 1,221,637 | 113,490 | 158.5 K to 113.5 K (-28.41 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Buy | M | 5.50 | 3,000 | 16,500 | 158,519 | 155.5 K to 158.5 K (+1.93 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Buy | M | 1.76 | 10,625 | 18,700 | 155,519 | 144.9 K to 155.5 K (+7.33 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Sell | S | 26.26 | 15,000 | 393,900 | 83,398 | 98.4 K to 83.4 K (-15.24 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Buy | M | 11.66 | 15,000 | 174,900 | 98,398 | 83.4 K to 98.4 K (+17.99 %) |
| Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 7.97 | 11,500 | 91,655 | 0 | |
| Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 7.97 | 3,500 | 27,895 | 11,500 | |
| Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 30.00 | 11,500 | 345,000 | 61,329 | 72.8 K to 61.3 K (-15.79 %) |
| Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 7.97 | 11,500 | 91,655 | 72,829 | 61.3 K to 72.8 K (+18.75 %) |
| Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 31.29 | 3,500 | 109,515 | 61,329 | 64.8 K to 61.3 K (-5.40 %) |
| Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 7.97 | 3,500 | 27,895 | 64,829 | 61.3 K to 64.8 K (+5.71 %) |
| Nov 17 2017 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Payment of Exercise | F | 24.75 | 8,347 | 206,588 | 131,653 | 140 K to 131.7 K (-5.96 %) |
| Nov 17 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 24.75 | 2,204 | 54,549 | 126,396 | 128.6 K to 126.4 K (-1.71 %) |
| Nov 17 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Payment of Exercise | F | 24.75 | 2,609 | 64,573 | 255,396 | 258 K to 255.4 K (-1.01 %) |
| Nov 17 2017 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Payment of Exercise | F | 24.75 | 244 | 6,039 | 90,175 | 90.4 K to 90.2 K (-0.27 %) |
| Nov 17 2017 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Payment of Exercise | F | 24.75 | 1,290 | 31,928 | 90,419 | 91.7 K to 90.4 K (-1.41 %) |
| Nov 17 2017 | EXEL | EXELIXIS, INC. | Haley Patrick J. | Sr. Vice President, ... | Payment of Exercise | F | 24.75 | 2,205 | 54,574 | 91,709 | 93.9 K to 91.7 K (-2.35 %) |